Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy

Conventional chemotherapy is the most common therapeutic method for treating cancer by the application of small toxic molecules thatinteract with DNA and causecell death. Unfortunately, these chemotherapeutic agents are non-selective and can damage both cancer and healthy tissues,producing diverse s...

Full description

Bibliographic Details
Main Authors: Nataša Avramović, Boris Mandić, Ana Savić-Radojević, Tatjana Simić
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/12/4/298
id doaj-c51994560f7c4b17a9d5a1e1bc089f86
record_format Article
spelling doaj-c51994560f7c4b17a9d5a1e1bc089f862020-11-25T02:04:40ZengMDPI AGPharmaceutics1999-49232020-03-0112429810.3390/pharmaceutics12040298pharmaceutics12040298Polymeric Nanocarriers of Drug Delivery Systems in Cancer TherapyNataša Avramović0Boris Mandić1Ana Savić-Radojević2Tatjana Simić3Institute of Medical Chemistry, Faculty of Medicine, University of Belgrade, 11000 Belgrade, SerbiaFaculty of Chemistry, University of Belgrade, Studentski trg 12–16, 11000 Belgrade, SerbiaInstitute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, 11000 Belgrade, SerbiaInstitute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, 11000 Belgrade, SerbiaConventional chemotherapy is the most common therapeutic method for treating cancer by the application of small toxic molecules thatinteract with DNA and causecell death. Unfortunately, these chemotherapeutic agents are non-selective and can damage both cancer and healthy tissues,producing diverse side effects, andthey can have a short circulation half-life and limited targeting. Many synthetic polymers have found application as nanocarriers of intelligent drug delivery systems (DDSs). Their unique physicochemical properties allow them to carry drugs with high efficiency,specificallytarget cancer tissue and control drug release. In recent years, considerable efforts have been made to design smart nanoplatforms, including amphiphilic block copolymers, polymer-drug conjugates and in particular pH- and redox-stimuli-responsive nanoparticles (NPs). This review is focused on a new generation of polymer-based DDSs with specific chemical functionalities that improve their hydrophilicity, drug loading and cellular interactions.Recentlydesigned multifunctional DDSs used in cancer therapy are highlighted in this review.https://www.mdpi.com/1999-4923/12/4/298block copolymerspolymer-drug conjugatespolymeric nanocarrierscancer therapy
collection DOAJ
language English
format Article
sources DOAJ
author Nataša Avramović
Boris Mandić
Ana Savić-Radojević
Tatjana Simić
spellingShingle Nataša Avramović
Boris Mandić
Ana Savić-Radojević
Tatjana Simić
Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
Pharmaceutics
block copolymers
polymer-drug conjugates
polymeric nanocarriers
cancer therapy
author_facet Nataša Avramović
Boris Mandić
Ana Savić-Radojević
Tatjana Simić
author_sort Nataša Avramović
title Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
title_short Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
title_full Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
title_fullStr Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
title_full_unstemmed Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
title_sort polymeric nanocarriers of drug delivery systems in cancer therapy
publisher MDPI AG
series Pharmaceutics
issn 1999-4923
publishDate 2020-03-01
description Conventional chemotherapy is the most common therapeutic method for treating cancer by the application of small toxic molecules thatinteract with DNA and causecell death. Unfortunately, these chemotherapeutic agents are non-selective and can damage both cancer and healthy tissues,producing diverse side effects, andthey can have a short circulation half-life and limited targeting. Many synthetic polymers have found application as nanocarriers of intelligent drug delivery systems (DDSs). Their unique physicochemical properties allow them to carry drugs with high efficiency,specificallytarget cancer tissue and control drug release. In recent years, considerable efforts have been made to design smart nanoplatforms, including amphiphilic block copolymers, polymer-drug conjugates and in particular pH- and redox-stimuli-responsive nanoparticles (NPs). This review is focused on a new generation of polymer-based DDSs with specific chemical functionalities that improve their hydrophilicity, drug loading and cellular interactions.Recentlydesigned multifunctional DDSs used in cancer therapy are highlighted in this review.
topic block copolymers
polymer-drug conjugates
polymeric nanocarriers
cancer therapy
url https://www.mdpi.com/1999-4923/12/4/298
work_keys_str_mv AT natasaavramovic polymericnanocarriersofdrugdeliverysystemsincancertherapy
AT borismandic polymericnanocarriersofdrugdeliverysystemsincancertherapy
AT anasavicradojevic polymericnanocarriersofdrugdeliverysystemsincancertherapy
AT tatjanasimic polymericnanocarriersofdrugdeliverysystemsincancertherapy
_version_ 1724941848833687552